AU468003B2 - Method of preparing medicinal compositions - Google Patents
Method of preparing medicinal compositionsInfo
- Publication number
- AU468003B2 AU468003B2 AU51068/73A AU5106873A AU468003B2 AU 468003 B2 AU468003 B2 AU 468003B2 AU 51068/73 A AU51068/73 A AU 51068/73A AU 5106873 A AU5106873 A AU 5106873A AU 468003 B2 AU468003 B2 AU 468003B2
- Authority
- AU
- Australia
- Prior art keywords
- medicinal compositions
- preparing medicinal
- preparing
- compositions
- medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- General Preparation And Processing Of Foods (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZAZA72/0698 | 1972-02-03 | ||
| ZA720698A ZA72698B (en) | 1972-02-03 | 1972-02-03 | Method of preparing medicinal compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU5106873A AU5106873A (en) | 1974-07-18 |
| AU468003B2 true AU468003B2 (en) | 1975-12-18 |
Family
ID=25564442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU51068/73A Expired AU468003B2 (en) | 1972-02-03 | 1973-01-12 | Method of preparing medicinal compositions |
Country Status (12)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2659466A1 (de) * | 1976-12-30 | 1979-02-15 | Roecar Holdings Nv | Steroline und deren verwendung |
| KR830005852A (ko) * | 1980-07-18 | 1983-09-14 | 미첼 페터 잭슨 | 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법 |
| JPS5874619A (ja) * | 1981-10-29 | 1983-05-06 | Nippon Shinyaku Co Ltd | リポソ−ム及びその製法 |
| DE3829643A1 (de) * | 1988-09-01 | 1990-03-15 | Roecar Holdings Nv | Phyto- und zoosterole und deren derivate mit verbesserter wasserloeslichkeit |
| EP0509656B1 (en) * | 1991-03-28 | 1996-09-18 | Rooperol (Na) Nv | Compositions of phytosterols and phytosterolins as immunmodulators |
| SE512958C2 (sv) | 1998-04-30 | 2000-06-12 | Triple Crown Ab | Kolesterolsänkande komposition innehållande beta-sitosterol och/eller beta-sitostanol samt förfarande för dess framställning |
| SE517769C2 (sv) | 1999-10-29 | 2002-07-16 | Triple Crown Ab | Kolesterol och blodfettsänkande komposition, innehållande fytosteroler, blandade med monoglycerider |
| US7306819B2 (en) | 2002-06-12 | 2007-12-11 | The Coca-Cola Company | Beverages containing plant sterols |
| MXPA04012456A (es) | 2002-06-12 | 2005-02-17 | Coca Cola Co | Bebidas que contienen esteroles vegetales. |
| MY142989A (en) * | 2004-03-10 | 2011-02-14 | Bayer Schering Pharma Ag | Stabilised supersaturated solids of lipophilic drugs |
| EP2238979A1 (en) * | 2009-04-06 | 2010-10-13 | LEK Pharmaceuticals d.d. | Active pharmaceutical ingredient adsorbed on solid support |
-
1972
- 1972-02-03 ZA ZA720698A patent/ZA72698B/xx unknown
-
1973
- 1973-01-02 GB GB13973A patent/GB1365661A/en not_active Expired
- 1973-01-10 CA CA160,948A patent/CA1028952A/en not_active Expired
- 1973-01-12 IE IE55/73A patent/IE37464B1/xx unknown
- 1973-01-12 AU AU51068/73A patent/AU468003B2/en not_active Expired
- 1973-01-12 BE BE794027D patent/BE794027A/xx not_active IP Right Cessation
- 1973-01-12 IL IL41289A patent/IL41289A/xx unknown
- 1973-01-18 ES ES410733A patent/ES410733A1/es not_active Expired
- 1973-01-24 DE DE2303247A patent/DE2303247A1/de not_active Ceased
- 1973-01-30 NL NL7301301A patent/NL7301301A/xx not_active Application Discontinuation
- 1973-02-02 FR FR7303776A patent/FR2173987B1/fr not_active Expired
- 1973-02-05 AT AT99173*#A patent/AT332530B/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA1028952A (en) | 1978-04-04 |
| IL41289A (en) | 1975-12-31 |
| BE794027A (fr) | 1973-05-02 |
| DE2303247A1 (de) | 1973-08-09 |
| IE37464B1 (en) | 1977-08-03 |
| FR2173987B1 (enrdf_load_stackoverflow) | 1977-10-28 |
| GB1365661A (en) | 1974-09-04 |
| IE37464L (en) | 1973-08-03 |
| FR2173987A1 (enrdf_load_stackoverflow) | 1973-10-12 |
| ZA72698B (en) | 1973-09-26 |
| IL41289A0 (en) | 1973-03-30 |
| AT332530B (de) | 1976-10-11 |
| AU5106873A (en) | 1974-07-18 |
| ES410733A1 (es) | 1976-04-01 |
| ATA99173A (de) | 1976-01-15 |
| NL7301301A (enrdf_load_stackoverflow) | 1973-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1033727A (en) | Preparation of w-pentanorprostaglandins | |
| AU467772B2 (en) | Method of preparing amidosilanes | |
| CA1020554A (en) | Preparation of thiocarbamylsulfenamides | |
| AU468003B2 (en) | Method of preparing medicinal compositions | |
| CA1008456A (en) | Preparation of 2-pyrrolidone | |
| CA1014161A (fr) | Procede de preparation de thiazolsulfenamides | |
| CA993885A (en) | Preparation of 2-alkoxy-5-alkylsulphonyl-benzoic acids | |
| CA984579A (en) | Preparation of 238pu16o2 | |
| CA1008457A (en) | Preparation of 2-pyrrolidinone | |
| CA999002A (en) | Preparation of nitrophenylpyridines | |
| AU472072B2 (en) | Preparation of 3-fluoro-d-alanine | |
| CA1013674A (en) | Method of contraception by the administration of stage-combination preparations | |
| CA1028701A (en) | Preparation of thiocarbamylsulfenamides | |
| CA884280A (en) | Method of making pharmaceutical compositions | |
| CA1018986A (en) | Process of preparation of benzopyrans | |
| CA899911A (en) | Preparation of perchlorofluoropropanes | |
| CA895859A (en) | Preparation of 21-fluoro-steroids | |
| CA889866A (en) | Preparation of methallylsilanes | |
| CA892042A (en) | Preparation of phenazine-di-n-oxides | |
| CA915160A (en) | Preparation of piperidyl-steroids | |
| CA893149A (en) | Preparation of perfluoroolefines | |
| AU488391B2 (en) | Preparation of 2-nitro-4-amino-phenylaniline | |
| AU483158B2 (en) | Preparation of phosphonothioureides | |
| CA895293A (en) | Preparation of 7-halolincomycins | |
| CA912560A (en) | Preparation of amino-s-triazines |